Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Hoffmann GB"'
Autor:
Ten Hacken E; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: elt4010@med.cornell.edu., Gruber M; CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Hernández-Sánchez M; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain., Hoffmann GB; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Baranowski K; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Redd RA; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA., Clement K; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Molecular Pathology Unit, Center for Cancer Research and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, MA, USA., Livak K; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Translational Immunogenomics Laboratory, Dana Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: cwu@partners.org.
Publikováno v:
STAR protocols [STAR Protoc] 2023 Dec 15; Vol. 4 (4), pp. 102165. Date of Electronic Publication: 2023 Sep 18.
Autor:
ten Hacken E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Hernández Sánchez M; The Institute of Cancer Molecular and Cellular Biology-Cancer Research Center, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Departament of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain., Clement K; Center for Cancer Research, and Center for Computational and Integrative Biology, Molecular Pathology Unit, Massachussetts General Hospital, Boston, MA., Hoffmann GB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Regis FF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Witten E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Li S; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Pinello L; Center for Cancer Research, and Center for Computational and Integrative Biology, Molecular Pathology Unit, Massachussetts General Hospital, Boston, MA., Livak KJ; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Aug 22; Vol. 7 (16), pp. 4514-4517.
Autor:
Takashima K, Lee DJ, Trovero MF, Rothi MH, Mistry M, Zhang Y, Li Z, Davis CP, Li Z, Natale J, Schmid E, Al Haddad J, Hoffmann GB, Dietmann S, Sui SH, Oshiumi H, Lieberman J, Greer EL
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jun 13. Date of Electronic Publication: 2023 Jun 13.
Autor:
Ten Hacken E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Sewastianik T; Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hoffmann GB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gruber M; CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Clement K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Molecular Pathology Unit, Center for Cancer Research and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité - Universitätsmedizin Berlin (corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin), Berlin, Germany., Redd RA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ruthen N; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts., Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France., Sholokhova A; Department of Applied Mathematics, University of Washington, Seattle, Washington., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, Service d'Hématologie Biologique, Pôle Laboratoires, Nancy, France., Guieze R; CHU Clermont Ferrand, Clermont Ferrand, France., Lucas F; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Hernández-Sánchez M; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain., Baranowski K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Southard J; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts., Joyal H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Billington L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Regis FFD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Witten E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uduman M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel., Li S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts., Lyu H; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts., Vaisitti T; Department of Medical Sciences, University of Torino, Turin, Italy., Deaglio S; Department of Medical Sciences, University of Torino, Turin, Italy., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, Service d'Hématologie Biologique, Pôle Laboratoires, Nancy, France., Stilgenbauer S; Department III of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Tausch E; Department III of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Livak KJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts., Bozic I; Department of Applied Mathematics, University of Washington, Seattle, Washington., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Carrasco RD; Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2023 Mar 01; Vol. 4 (2), pp. 150-169.
Autor:
Biran A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kretzmer H; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany., Ten Hacken E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parvin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lucas F; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Uduman M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Gutierrez C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dangle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Billington L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Regis FF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rassenti LZ; Moores Cancer Center, University of California San Diego Health, La Jolla, California., Mohammad A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Hoffmann GB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Stevenson K; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zheng M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Witten E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Sun C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kipps TJ; Moores Cancer Center, University of California San Diego Health, La Jolla, California., Aster JC; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Gnirke A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Wang L; Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, California., Carrasco RD; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Meissner A; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. cwu@partners.org.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2021 Dec 15; Vol. 81 (24), pp. 6117-6130. Date of Electronic Publication: 2021 Oct 22.
Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β.
Autor:
Tartell MA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.; Program in Virology, Harvard Medical School, Boston, MA 02115., Boulias K; Department of Pediatrics, Initiative for RNA Medicine, Harvard Medical School, Boston, MA 02115.; Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115., Hoffmann GB; Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115., Bloyet LM; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110., Greer EL; Department of Pediatrics, Initiative for RNA Medicine, Harvard Medical School, Boston, MA 02115; spjwhelan@wustl.edu eric.greer@childrens.harvard.edu.; Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115., Whelan SPJ; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110; spjwhelan@wustl.edu eric.greer@childrens.harvard.edu.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jul 20; Vol. 118 (29).
Autor:
Gazon H; Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), Sart-Tilman, Liège, Belgium.; Molecular Biology, Teaching and Research Centre (TERRA), Gembloux, Belgium; and., Chauhan PS; Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), Sart-Tilman, Liège, Belgium.; Molecular Biology, Teaching and Research Centre (TERRA), Gembloux, Belgium; and., Porquet F; Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), Sart-Tilman, Liège, Belgium.; Molecular Biology, Teaching and Research Centre (TERRA), Gembloux, Belgium; and., Hoffmann GB; Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), Sart-Tilman, Liège, Belgium.; Molecular Biology, Teaching and Research Centre (TERRA), Gembloux, Belgium; and., Accolla R; Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Willems L; Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied Genoproteomics (GIGA), Sart-Tilman, Liège, Belgium.; Molecular Biology, Teaching and Research Centre (TERRA), Gembloux, Belgium; and.
Publikováno v:
Blood advances [Blood Adv] 2020 Nov 10; Vol. 4 (21), pp. 5574-5579.
Autor:
Hamaidia M; Molecular and Cellular Epigenetics (Groupe Interdisciplinaire de Génoprotéomique Appliquée [GIGA]), Liège, Belgium.; Molecular Biology, TERRA, Gembloux, Belgium., Gazon H; Molecular and Cellular Epigenetics (Groupe Interdisciplinaire de Génoprotéomique Appliquée [GIGA]), Liège, Belgium., Hoyos C; Molecular and Cellular Epigenetics (Groupe Interdisciplinaire de Génoprotéomique Appliquée [GIGA]), Liège, Belgium.; Molecular Biology, TERRA, Gembloux, Belgium., Hoffmann GB; Molecular and Cellular Epigenetics (Groupe Interdisciplinaire de Génoprotéomique Appliquée [GIGA]), Liège, Belgium.; Molecular Biology, TERRA, Gembloux, Belgium., Louis R; Department of Pneumology, University Hospital of Liège, Liège, Belgium., Duysinx B; Department of Pneumology, University Hospital of Liège, Liège, Belgium., Willems L; Molecular and Cellular Epigenetics (Groupe Interdisciplinaire de Génoprotéomique Appliquée [GIGA]), Liège, Belgium.; Molecular Biology, TERRA, Gembloux, Belgium.
Publikováno v:
JCI insight [JCI Insight] 2019 Sep 19; Vol. 4 (18). Date of Electronic Publication: 2019 Sep 19.
Autor:
Wu, Yuting1 (AUTHOR), Pu, Xi1 (AUTHOR), Wu, Sihui1 (AUTHOR), Zhang, Yiran1 (AUTHOR), Fu, Shengqiao2 (AUTHOR), Tang, Haowen2 (AUTHOR), Wang, Xu2 (AUTHOR) jsdxwx@126.com, Xu, Min1,3 (AUTHOR) peterxu1974@163.com
Publikováno v:
Cancer Cell International. 10/1/2023, Vol. 23 Issue 1, p1-12. 12p.
Autor:
Senchina DS; Department of Biology, Drake University, 2507 University Avenue, Des Moines, IA 50311, USA. dssenchina@drake.edu, Strauch JH, Hoffmann GB, Shah NB, Laflen BK, Dumke BL, Dao CT, Dias AS, Perera MA
Publikováno v:
Journal of alternative and complementary medicine (New York, N.Y.) [J Altern Complement Med] 2011 Apr; Vol. 17 (4), pp. 375-7. Date of Electronic Publication: 2011 Apr 07.